WASHINGTON, Nov. 6 (UPI) -- The U.S. Food and Drug Administration has rejected research data for a long-acting version of the diabetes drug Byetta.
WASHINGTON, Aug. 18 (UPI) -- The U.S. Food and Drug Administration has asked the maker of the type 2 diabetes drug Byetta to include a warning for acute pancreatitis, officials said.
WASHINGTON, May 12 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of a drug designed for the treatment of restless legs syndrome.
WASHINGTON, April 30 (UPI) -- The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome.
WASHINGTON, Oct. 16 (UPI) -- The U.S. Food and Drug Administration announced it suspects a link between usage of Byetta, a type 2 diabetes drug, and acute pancreatitis.
NEW YORK, July 2 (UPI) -- Sanofi-Aventis is withdrawing its application for U.S. approval of its potential obesity drug on reports that it causes suicidal thoughts.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
INDIANAPOLIS, Sept. 21 (UPI) -- Eli Lilly and Amylin said Thursday their type 2 diabetes drug Byetta (exenatide) has been recommended for approval in Europe.
WASHINGTON, May 31 (UPI) -- The U.S. Food and Drug Administration has approved a drug similar to a leading human growth hormone and sparked a battle over generic biotechnology drugs.
WASHINGTON, Dec. 5 (UPI) -- The Food and Drug Administration said Monday it has approved a generic version of Roche's Copegus tablets for hepatitis C.
